Bhutan vs Qatar: The number of people with susceptibility test result for rifampicin
Bhutan
419
in 2021
Qatar
411
in 2021
Bhutan rank
83rd
Qatar rank
84th
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Qatar
How they compare
Bhutan currently reports 419 against 411 in Qatar, a difference of 8.
Across all 5 years both countries report, Bhutan has been ahead every year.
Bhutan ranks 83rd and Qatar ranks 84th of 155 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 400.33 | 297.67 | 102.67 | Bhutan |
| 2020s | 426.5 | 392.5 | 34 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Qatar?
- Bhutan, at 419 against 411 in Qatar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Qatar?
- 8, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd and Qatar ranks 84th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.